首页 / 院系成果 / 成果详情页

Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association 期刊论文

编号：

a412a7b3-bb0b-4f0f-90b3-ce926840c0c4
作者：

Cao, Bin^[1];Huang, Yi^[2];She, DanYang^[3];Cheng, QiJian^[4];Fan, Hong^[5];Tian, XinLun^[6];Xu, JinFu^[7];Zhang, Jing(张静)^[8]Chen, Yu^[9];Shen, Ning^[10];Wang, Hui^[11];Jiang, Mei^[12];Zhang, XiangYan^[13];Shi, Yi^[14];He, Bei^[10];He, LiXian(何礼贤)^[8]Liu, YouNing^[3];Qu, JieMing^[4];
语种：

English
期刊：

CLINICAL RESPIRATORY JOURNAL ISSN：1752-6981 2018 年 12 卷 4 期 (1320 - 1360) ; APR
收录：
关键词：

community-acquired pneumonia adult antimicrobial therapy aetiology diagnosis adjunctive therapy prevention
摘要：

Community-acquired pneumonia (CAP) in adults is an infectious disease with high morbidity in China and the rest of the world. With the changing pattern in the etiological profile of CAP and advances in medical techniques in diagnosis and treatment over time, Chinese Thoracic Society of Chinese Medical Association updated its CAP guideline in 2016 to address the standard management of CAP in Chinese adults. Extensive and comprehensive literature search was made to collect the data and evidence for experts to review and evaluate the level of evidence. Corresponding recommendations are provided appropriately based on the level of evidence. This updated guideline covers comprehensive topics on CAP, including aetiology, antimicrobial resistance profile, diagnosis, empirical and targeted treatments, adjunctive and supportive therapies, as well as prophylaxis. The recommendations may help clinicians manage CAP patients more effectively and efficiently. CAP in pediatric patients and immunocompromised adults is beyond the scope of this guideline. This guideline is only applicable for the immunocompetent CAP patients aged 18 years and older. The recommendations on selection of antimicrobial agents and the dosing regimens are not mandatory. The clinicians are recommended to prescribe and adjust antimicrobial therapies primarily based on their local etiological profile and results of susceptibility testing, with reference to this guideline.
推荐引用方式
GB/T 7714：

Cao Bin,Huang Yi,She Dan-Yang, et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association [J].CLINICAL RESPIRATORY JOURNAL,2018,12(4):1320-1360.
APA：

Cao Bin,Huang Yi,She Dan-Yang,Cheng Qi-Jian,&Qu Jie-Ming.(2018).Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association .CLINICAL RESPIRATORY JOURNAL,12(4):1320-1360.
MLA：

Cao Bin, et al. "Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association" .CLINICAL RESPIRATORY JOURNAL 12,4(2018):1320-1360.

浏览次数：15  下载次数：0

分享到：

浏览次数：15

下载次数：0

打印次数：0